Production of chemoattractants by bronchial epithelial cells may contribute to the local accumulation of inflammatory cells in patients with bronchial asthma and other pulmonary diseases. Recently, interleukin (IL)-16 (lymphocyte chemoattractant factor) was reported to be a potent chemotactic stimulus for CD4 ϩ T lymphocytes and eosinophils, the types of leukocyte found in the proximity of bronchial epithelium in asthmatic individuals. To test the possibility that bronchial epithelial cells produce IL-16, we analyzed RNA and culture supernatants from the human bronchial epithelial cell line BEAS-2B, using reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. BEAS-2B constitutively expressed IL-16 messenger RNA (mRNA) and protein; IL-16 expression was significantly upregulated in a concentration-dependent manner within 24 h by stimulation with histamine, IL-1 ␤ , or tumor necrosis factor (TNF)-␣ whereas interferon-␥ did not significantly increase IL-16. Findings in BEAS-2B cells were confirmed in primary bronchial epithelial cells. Using TA cloning, IL-16 was cloned from BEAS-2B airway epithelial cells. Sequence analysis confirmed its near identity with lymphocyte-derived IL-16. The combination of IL-1 ␤ and TNF-␣ had an additive effect on IL-16 expression. This combination of cytokines also had a priming effect on histamine-induced IL-16 mRNA expression, which was observed within 24 h and which increased to at least 48 h after stimulation. The IL-16 expression induced by histamine and combined cytokines was significantly inhibited by pretreatment with the protein synthesis inhibitor cycloheximide (10 g/ml). Pretreatment with dexamethasone also significantly suppressed the expression of IL-16, in a concentration-dependent manner. Sputum samples from asthmatic subjects were found to have higher levels of IL-16 than were samples from subjects with other pulmonary inflammatory diseases. These findings suggest that bronchial epithelial cells have the capacity to produce IL-16 after stimulation with histamine, IL-1 ␤ , and TNF-␣ , and raise the possibility that epithelium-derived IL-16 may play a role in recruitment of eosinophils and CD4 ϩ T lymphocytes in the airways. Downregulation of IL-16 expression by dexamethasone suggests that glucocorticoids may inhibit airway inflammation partly by suppressing the synthesis of inflammatory cytokines including 
Inflammatory changes in airway mucosa have been implicated in the pathogenesis of bronchial asthma. Mucosal invasion by activated eosinophils has been particularly recognized, and eosinophil products are suspected of playing an important role in the pathogenesis of asthma and other inflammatory diseases of the airways (1) . CD4 ϩ T cells have also been shown to be recruited to airway mucosa and bronchoalveolar lavage fluid (BALF) in asthmatic individuals (2) . The importance of CD4 ϩ T cells is indicated by in vivo studies in animal models of asthma in which airway hypersensitivity and eosinophilia were lacking in CD4 ϩ T-cell-deficient mice after antigen challenge (3, 4) . Conversely, normal rats receiving transfers of sensitized CD4 ϩ T cells developed into late-phase responders, with infiltration of eosinophils following antigen challenge (5) . It has been suggested that the role of CD4 ϩ T cells in asthma may be mediated by release of cytokines including interleukin (IL)-3, IL-4, and IL-5, and granulocyte-macrophage colony-stimulating factor (GM-CSF), which are involved in the proliferation, prolongation of survival, acti-vation, and migration of eosinophils (2, (6) (7) (8) (9) (10) (11) . Thus, the recruitment of eosinophils and CD4 ϩ T cells into the airway may be a crucial occurrence in asthmatic individuals. Recent studies have suggested that airway inflammation may be perpetuated by bronchial epithelial cells themselves. Epithelial cells have been shown to produce numerous inflammatory mediators, such as platelet activating factor (12) and prostaglandins (13) . Bronchial epithelial cells also produce a wide variety of proinflammatory cytokines, such as IL-1, IL-6, IL-8, GM-CSF, tumor necrosis factor (TNF), macrophage chemotactic protein (MCP)-1, and regulated on activation, normal T cell expressed and secreted (RANTES) (12) (13) (14) (15) (16) . Production of cytokines and chemoattractants by bronchial epithelial cells may contribute to the local accumulation of inflammatory cells in patients with bronchial asthma and other airway inflammatory diseases.
Recently, IL-16 has been reported to be a potent chemotactic stimulus for CD4 ϩ T lymphocytes (17) and eosinophils (18) . IL-16 is a 14-kD protein that is released within 2-4 h from eosinophils (19) and CD8
ϩ T cells stimulated with histamine or serotonin (20, 21) . Cruikshank, and coworkers recently identified IL-16 and macrophage inflammatory protein (MIP)-1 ␣ in BALF at 6 h after antigen challenge of asthmatic subjects, and showed that the great majority of the lymphocyte chemoattractant activity in the BALF was attributable to IL-16 and MIP-1 ␣ (22). Bellini and associates have reported observing chemotactic activity for CD4 ϩ T cells in the supernatants of primary bronchial epithelial cell cultures isolated from patients with bronchial asthma following in vitro stimulation with histamine (10 Ϫ 6 M) for 48 h (23), and speculated that IL-16 might have been responsible for this activity. To test the possibility that bronchial epithelial cells produce IL-16, we analyzed messenger RNA (mRNA) and supernatants from human bronchial epithelial cells, using reverse transcription-polymerase chain reaction and enzyme linked immunosorbent assay (ELISA). We found in the study reported here that epithelial cells express IL-16 mRNA and protein, and that it is increased in a concentration-dependent manner 24 h after stimulation with histamine, IL-1 ␤ , and TNF-␣ , but not interferon (IFN)-␥ . The combination of IL-1 ␤ and TNF-␣ showed an additive effect, and expression of IL-16 mRNA was significantly suppressed by the glucocorticoid dexamethasone.
Materials and Methods

Reagents
The following reagents were purchased from the indicated sources: Hanks' F12 medium (Biowhitaker, Walkersville, MD), Dulbecco's modified Eagle's medium (DMEM), Ca and stored as 0.1 M stock solutions in dimethylsulfoxide (DMSO) at Ϫ 20 Њ C. Human recombinant TNF-␣ , IL-1 ␤ , and IFN-␥ were purchased from R&D Systems (Minneapolis, MN) and were stored as 1 g/ml stock solutions in phosphate-buffered saline supplemented with 0.1% bovine serum albumin (BSA) at Ϫ 20 Њ C.
Cell Culture
The study utilized the BEAS-2B cell line (24) , which was derived from human bronchial epithelium transformed by an adenovirus 12-SV40 hybrid virus. This cell line was generously supplied by Dr. Curtis Harris of the National Institutes of Health, Bethesda, MD. BEAS-2B cells were cultured in F12/DMEM supplemented with 5% FCS, penicillin (100 U/ml), and streptomycin (100 mg/ml) in 25-cm 2 tissue culture flasks at 37 Њ C in 5% CO 2 . Only cells that had reached 80-90% confluence were used for experiments. Viability of cells, assessed by staining with erythrosin B, was always more than 98% of cells harvested, and viability was more than 80% for cells treated with cycloheximide. Additional studies utilized NHBE 4683 normal human bronchial epithelial cells (Lot No. 17714; Clonetics Corp.), which were obtained from a 60-yr-old female donor. NHBE 4683 cells were cultured in a complete medium (bronchial/tracheal epithelial cell growth medium) that is a modified light harvesting complex-9 formulation, and which was supplemented with bovine pituitary extract (7.5 mg/ml), hydrocortisone (0.5 g/ml), human epithelial growth factor (0.5 g/ml), epinephrine (0.5 mg/ml), transferrin (10 mg/ml), insulin (0.5 mg/ml), retinoic acid (0.1 g/ml), triiodothyronine (6.5 g/ml), gentamycin (50 mg/ ml), and bovine serum albumin, fatty acid free (50 mg/ml).
Preparation of mRNA and RT-PCR Analysis
A total of 5-8 ϫ 10 6 cells/flask were detached by incubation in 0.05% trypsin and 0.53 mM EDTA-4Na in HBSS. Total mRNA was then extracted from the cells with the RNAzol B extraction technique (25) , and was stored as a 1 g/ l stock solution in diethylpyrocarbonate-treated water at Ϫ 80 Њ C. An RT-PCR procedure was performed to determine relative quantities of mRNA for IL-16, using an adaptation of methods described elsewhere (26, 27) . Briefly, the first-strand complementary DNA (cDNA) was synthesized from mRNA, using oligo-dT primer. A 20-l reaction volume mix, containing 1 g mRNA, 2.5 pmol oligodT primer, 4 l of 5 ϫ synthesis buffer (250 mM Tris-HCl, 375 mM KCl, 15 mM MgCl 2 , pH 8.3), 10 mM DTT, 2 mM deoxynucleotide triphosphate (dNTP) mixture, 20 U RNase inhibitor, and 100 U MMLV reverse transcriptase, was incubated at 37 Њ C for 30 min in an Omnigene thermocycler (Hybaid, Holbrook, NY). At the end of this incubation, the reaction was stopped by heating at 99 Њ C for 5 min, and the reaction mixuture was then cooled to room temperature (RT). Five microliters of cDNA from the previ- To verify that equal amounts of RNA were added in each PCR within an experiment, primers for the housekeeping gene ␤ -actin were used in each experiment. For IL-16 and ␤ -actin gene products, the optimum number of cycles was determined experimentally, and was defined as the number of cycles that would produce a detectable concentration that was well below saturating conditions. The IL-16 PCR primers consisted of base pairs 1,504-1,893 of the coding region of the IL-16 gene, and had the sequences 5 Ј -ATGCCCGACCTCAACTCC-3 Ј and 5 Ј -CTAGGAG-TCTCCAGCAGC-3 Ј ; the expected PCR product size is 389 bp. The primers for ␤ -actin were 5 Ј -TGACGGGGT-CACCCACACTGTGCCCATCTA-3 Ј and 5 Ј -CTAGA-AGCATTGCGGTGGACGATGGAGGG-3 Ј ; the expected PCR product size is 600 bp. The PCR product was subjected to electrophoresis at 100 V on a 1.5% agarose gel in TAE buffer. PCR products were detected by ethidium bromide staining. PCR products in electrophoretic analyses were quantified by video densitometry, using a gel documentation system configured by UVP (San Gabriel) interfaced with a Macintosh Performa computer (Apple, Inc., Cupertino, CA) containing Image 1.53 software (NIH Public Software, National Institutes of Health, Bethesda, MD). The level of IL-16 expression was quantified by calculating the ratio of densitometric readings of the bands for IL-16 and ␤ -actin from the same cDNA. ␤ -Actin densitometric values did not usually differ by more than 1.5-fold. Changes in IL-16 expression were expressed as a percent of the level in unstimulated control cells.
Assessment of the Expression of IL-16 mRNA in Epithelial Cells
To assess the effect of stimuli on IL-16 gene expression, we treated epithelial cell monolayers with control medium, histamine (10 Ϫ 8 , 10 Ϫ 7 , 10 Ϫ 6 , 10 Ϫ 5 M), TNF-␣ (1, 10, 100 ng/ml), IL-1 ␤ (1, 10, 100 ng/ml), or IFN-␥ (1, 10, 100 ng/ml), or with combinations of these stimuli. For timecourse experiments, cultures were harvested after stimulation with either medium alone or histamine (10 Ϫ 6 M), IL-1 ␤ (10 ng/ml), and TNF-␣ (100 ng/ml) for 3, 6, 12, 24, or 48 h. To assess the protein synthesis-dependence of cytokine-induced IL-16 expression, we extracted total mRNA from cells pretreated for 2 h with either medium alone or with the protein synthesis inhibitor cycloheximide (10 g/ml) before stimulating the cells with the combination of histamine (10 Ϫ 6 M), IL-1 ␤ (10 ng/ml), and TNF-␣ (100 ng/ml). To assess the effect of glucocorticoids on IL-16 gene expression, cells were pretreated for 24 h with dexamethasone (10 Ϫ 11 , 10
, 10 Ϫ 7 M) or an equivalent amount of DMSO diluent before stimulation. ␤ -Estradiol (10 Ϫ 7 M) was used as a control steroid. Specific IL-16 and ␤ -actin mRNAs were visualized as PCR products in electrophoresis gels appropiate for the expected molecular sizes of these mRNAs. When IL-16 or ␤ -actin cDNA was amplified through 28 PCR cycles, a linear correlation was observed between the quantity of input RNA and the optical density (OD) of the PCR product (data not shown).
ELISA Analysis of IL-16 in Epithelial Cell Supernatants
BEAS-2B and NHBE 4683 cells were grown to near confluence (n ϭ 4) and stimulated with histamine (10 Ϫ6 M), IL-1␤ (100 ng/ml), and TNF-␣ (100 ng/ml). IL-16 in the culture supernatant was measured at various time points up to 48 h after stimulation, as well as in supernatant from unstimulated cells, by using a solid-phase sandwich ELISA (BioSource International, Inc.). The sensitivity of this assay was approximately 5 pg/ml. 
Analysis of IL-16 mRNA Stability
To investigate the stabilizing effect of histamine, IL-1, or TNF-␣ on IL-16 mRNA, we incubated near-confluent cultured BEAS-2B cells with histamine (10 Ϫ7 M) and IL-1␤ (10 ng/ml) or TNF-␣ (100 ng/ml) for 48 h. Immediately after the incubation, cells were incubated with actinomycin D (5 g/ml). The level of expression of IL-16 mRNA was investigated immediately and after 3, 10, and 20 h.
Sequence Analysis of PCR Products
The TA cloning method was utilized to clone PCR products from the BEAS-2B cell line with the pGEM-T vector system (28, 29) . The purified clone products from BEAS-2B cells were sequenced by using SP6 and T7 primers with the fluorescent dideoxy method on an automated DNA sequencer (Model 373a; Perkin Elmer Corp., Foster City, CA). All consensus sequences were generated with Sequencer Software (Gene Codes Corp., Ann Arbor, MI). The consensus sequence of four of six clones derived from the RT-PCR products of RNA from BEAS-2B cells was identical with that of the published sequence of the coding region of the lymphocyte IL-16 gene (17) . However, in two separately cloned cDNA products we observed a missing codon (-CAG-), as also described elsewhere (30) .
Analysis of IL-16 Proteins in Sputum
A group of 23 patients with chronic symptoms of bronchial asthma (14 men and nine women) were examined ( Table   1 ). All patients were treated at the Department of Medicine and Clinical Immunology of Dokkyo University School of Medicine, and were enrolled after informed consent was obtained. The patients' mean age was 36 yr; the patients ranged in age from 25 to 69 yr. Asthma was defined according to the international consensus report on the diagnosis and management of asthma in patients who had had episodic attacks of dyspnea with wheezing and a fluctuation in FEV 1 or in peak expiratory flow of more than 20%. The patients were classified according to severity of asthma: eight cases were classified as mild asthma, defined as dyspnea attacks less often than three times a week, and 15 cases were classified as moderate asthma, defined as dyspnea attacks more often than three times a week. No cases were classified as severe asthma, defined as daily dyspnea attacks that required administration of corticosteroids. All of the patients were taking bronchodilators only. Sputum was collected during symptom-free states after inhalation of 10% saline, using a DeVilbiss 646 nebulizer for 3-5 min. As a disease control, sputum samples were collected from 10 patients with diffuse panbronchiolitis and seven patients with bronchiectasis. They were 10 men and 7 women ranging in age from 19 to 62 yr (Table 1).
Preparation of Sputum
Sputum samples were treated as described previously (31) . Briefly, sputum was expectorated into a Petri dish and transferred to a tube after the watery portion was removed. The sputum was mixed with a vortex mixer for 1 min, after a 3-fold volume of physiologic saline was added. Samples were then centrifuged at 4ЊC for 30 min at 40,000 ϫ g. The supernatant was collected through a 4-m filter (Biofield, Tokyo, Japan) and is referred to as the sputum extract. The sputum extracts were stored at Ϫ20ЊC until assay for IL-16. 
Statistical Analysis
Data are expressed as mean Ϯ SD. Statistical analysis of between-group comparisons was done through analysis of variance, with post hoc analysis through Fisher's protected least-squares difference test). A value of P Ͻ 0.05 was considered significant.
Results
Densitometric analysis of RT-PCR products showed that BEAS-2B cells exhibited basal expression of IL-16 mRNA (Figure 1) . Activation of BEAS-2B cells with TNF-␣ or IL-1␤ for 24 h increased IL-16 mRNA expression in a concentration-dependent manner. The maximum IL-16 induction was observed at a concentration of 100 ng/ml of TNF-␣ and 10 ng/ml of IL-1␤. Expression of IL-16 mRNA did not significantly change after 24 h of incubation of BEAS-2B cells with IFN-␥ ( Figure 1C) . The combination of IL-1␤ (10 ng/ml) and TNF-␣ (100 ng/ml) caused an additive upregulation of IL-16 mRNA at 24 h (Figure 2 ). When combined with the other cytokines, IFN-␥ failed to show a significant additive or synergistic effect (not shown). Histamine-induced expression of IL-16 mRNA was magnified by combination of histamine with IL-1␤ (10 ng/ml) and TNF-␣ (100 ng/ml); in this case, even the lowest concentration of histamine tested (10 Ϫ7 M) induced significant expression of IL-16 mRNA (Figure 3) . These results indicate that signaling mechanisms for IL-1␤, TNF-␣, and histamine may be distinct. Time-course experiments showed that expression of IL-16 mRNA was increased by 24 h and continued to rise at 48 h after stimulation with the combination of histamine (10 Ϫ6 M), IL-1␤ (10 ng/ml), and TNF-␣ (100 ng/ml) (Figure 4) .
Expression of IL-16 mRNA at 48 h after stimulation was significantly inhibited by pretreatment with the protein synthesis inhibitor cycloheximide (10 g/ml), indicating that protein synthesis may be required for transcriptional induction of IL-16 mRNA ( Figure 5A ). To determine whether activating stimuli increased IL-16 mRNA indirectly via stabilization, we stimulated BEAS-2B cells with histamine, IL-1␤, and TNF-␣ for 48 h and then treated them with actinomycin D to block further transcription. The level of mRNA was assayed immediatedly and then periodically over a 20-h period. Figure 5B shows that the decay of mRNA was similar in unstimulated and stimulated cells. Half-lives of IL-16 mRNA in unstimulated and histamine-stimulated cells were 8.3 and 15.7 h, respectively. The half-life after stimulation with TNF-␣ was 6.3 h, which was not influenced by histamine treatment. The half-life of IL-1␤-induced IL-16 mRNA was 3.2 h, which was prolonged to 8.2 h by histamine treatment ( Figure  5B ). The expression of IL-16 mRNA was significantly suppressed by dexamethasone in a concentration-dependent manner after a 48 h incubation ( Figure 6 ). The maximum effect was observed at a dexamethasone concentration of 10 Ϫ7 M, whereas treatment with ␤-estradiol or DMSO alone had no effect on mRNA expression ( Figure 6 ).
To confirm the mRNA results and extend the findings to primary bronchial epithelial cells, we used an ELISA to measure IL-16 protein in supernatants of both BEAS-2B and primary bronchial epithelial cells. IL-16 levels increased in a time-dependent manner for up to 48 h in supernatants from stimulated cells. Unstimulated cells produced low levels of IL-16 throughout the experiment ( Figure 7A ). Dexamethasone reduced levels of IL-16 protein in supernatants of both BEAS-2B and NHBE 4683 cells that had been stimulated, but did not influence baseline levels of IL-16 protein ( Figure 7B ).
To determine whether IL-16 is increased in asthma, we collected sputum from 23 subjects with bronchial asthma and 17 controls with other airway diseases including panbronchiolitis and bronchiectasis. IL-16 levels in sputum extracts of asthmatic subjects were 639 Ϯ 89 pg/ml, which was significantly higher (P Ͻ 0.05) than levels in sputum extracts from control-disease subjects, which were 189 Ϯ 90 pg/ml. There were modestly higher levels in sputum from pateints with moderate asthma (683 Ϯ 55 pg/ml) than in those with mild asthma (558 Ϯ 86 pg/ml) (P ϭ 0.003).
Discussion
In the present study, human bronchial epithelial cells were found through a PCR-based assay and a specific ELISA to constitutively express IL-16 mRNA and protein. Sequence analysis of six independently isolated clones of IL-16 RNA from epithelial cells revealed identity of four of the clones to the reported sequence of lymphocyte-derived IL-16 mRNA (17) . Two clones were missing one codon previously described as being deleted in some human IL-16 alleles by Baier and colleagues (30) . IL-16 mRNA expression was significantly increased by stimulation with histamine, IL-1␤, or TNF-␣ in a concentration-dependent manner, whereas IFN-␥ did not significantly increase IL-16 mRNA. The combination of IL-1␤, histamine, and TNF-␣ caused a significant increase in IL-16 mRNA expression. Recently, Laberge and coworkers reported the expression of IL-16 mRNA in human bronchial epithelial cells in vivo as detected with immunohistochemistry and in situ hybridization (32, 33) . Two other reported sources of IL-16 are CD8 ϩ T cells (20, 21) and eosinophils (19) isolated from normal subjects. CD8
ϩ T cells release IL-16 within 4 h after stimulation with histamine at high concentrations (10 Ϫ4 -10 Ϫ2 M ) (21) . Eosinophils release IL-16 by 24 h after culture with GM-CSF (19) . In the same series of studies, it was reported that CD8 ϩ T cells and freshly isolated eosinophils constitutively express IL-16 mRNA. Because histamine did not upregulate IL-16 mRNA expression in CD8 ϩ T cells during a 4 h period in these studies, it was concluded that preformed IL-16 was secreted independently of transcriptional upregulation. We observed both constitutive and inducible expression of IL-16 mRNA and IL-16 protein in BEAS-2B and primary bronchial epithelial cells.
Pleiotropic proinflammatory cytokines such as IL-1␤, TNF-␣, and IFN-␥ have been observed in airway mucosa or BALF during symptomatic asthma or after antigen challenge in asthmatic patients (2, (34) (35) (36) (37) . These cytokines have thus been suggested to potentially play an important role in bronchial inflammation. TNF-␣ and/or IL-1␤ induce airway epithelial cells to express and/or release IL-6, GM-CSF, and the chemokines IL-8, MCP-1, granulocyte chemoattractant (GRO), RANTES, and MCP-4 (16, (38) (39) (40) . Interestingly, IL-1␤ and TNF-␣ are themselves produced in small amounts by bronchial epithelial cells (41) (42) (43) . The present study demonstrated that TNF-␣ and IL-1␤ also induce IL-16 in epithelial cells. Studies with specific blockers suggest a role for IL-1 and TNF in airway hyperreactivity in guinea pigs (44) and mice (45) . Although IFN-␥ may also be involved in airway inflammation, we found no significant effect of IFN-␥ on the expression of IL-16 mRNA. We detected IL-16 in the sputum of subjects with asthma as well as subjects with other airway inflammatory diseases. Whether the source of this IL-16 is epithelial cells has not been established. CD4
ϩ T cells are also involved in other airways diseases, including pulmonary sarcoidosis, hypersensitivity pneumonitis, allergic bronchopulmonary aspergillosis, eosinophilic pneumonias, and others.
Dexamethasone profoundly inhibited the expression of IL-16 induced by the combination of histamine, IL-1␤, and TNF-␣. An important molecular mechanism of steroid action in inhibiting cytokine production is now considered to be direct interaction between the activated glucocorticoid receptor and transcription factors such as NF-B or activator protein-1 (AP-1), which are heterodimeric transcription factors derived from the c-jun and fos oncogene subfamilies (46) (47) (48) . These factors are proteins that bind to regulatory sequences, usually in the 5Ј upstream promoter region of target genes, to regulate gene transcription. Expression of the c-fos protooncogene was observed in bronchial epithelium of asthmatic but not normal subjects (49) , and NF-B activation has been demonstrated in human lung and in airway epithelial cells (50) . Activation of AP-1 was observed in human lung after stimulation with TNF-␣ and IL-1␤ (51) (52) (53) (54) . It is thus conceivable that upregulation of IL-16 expression results from activation of these transcription factors by IL-1␤ and/or TNF-␣. Recently, Laberge and associates showed that treatment with steroid in vivo reduced IL-16 production in human subjects (33) .
Takizawa and colleagues have reported that histamine (10 Ϫ6 -10 Ϫ3 M) induces the release of IL-6, IL-8, and GM-CSF in epithelial cells at 6 h after stimulation, without an increase in steady-state levels of IL-6 mRNA, suggesting that some epithelial cytokines may be present intracellularly and may be secreted after stimulation with histamine (55) . However, histamine is also known to regulate the expression of some cytokine genes. Histamine was found to enhance IL-1␣-induced expression of IL-1␤ and IL-6 mRNA in mononuclear cells (56, 57) . Histamine also promoted expression of endothelin in epithelial cells (58) , and has been known to suppress lipopolysaccharide-induced TNF-␣ expression (59) . Our results suggest that histamine modulates the expression of IL-16 at the transcriptional level, directly or indirectly, in bronchial epithelial cells. Histamine was found by others to increase the expression of steady-state c-fos mRNA in airway smooth-muscle cells (60) and in bovine chromaffin cells (61) . Induction of c-fos and activation of AP-1 by histamine may thus be involved in the transcription of cytokine genes, including that for IL-16. Suppression of IL-16 gene upregulation by the protein synthesis inhibitor cycloheximide indicates that de novo protein synthesis may be involved in the activation of IL-16 gene transcription, supporting a model in which a secondary protein, like c-fos, is involved in the histamine effect. Similarly, the suppressive effect of dexamethasone on IL-16 mRNA expression could result from blockage of AP-1 and other transcription factors.
In conclusion, the present study showed that bronchial epithelial cells have the capacity to express IL-16 after stimulation with histamine, IL-1␤, and TNF-␣, and that glucocorticoids inhibit its expression. This finding, and the observation that IL-16 is present in the sputum of asthmatic subjects, suggests that epithelial-derived IL-16 protein may be involved in airway mucosal inflammation, and especially in the accumulation of eosinophils and CD4 ϩ T cells that is observed in patients with bronchial asthma, and could be a target of the antiinflammatory effects of glucocorticoids.
